KRAS and colorectal carcinoma: For KRAS‐mutated CRC patients, the pooled HR of ACM was 0.85 (95% CI 0.61‐1.18) (Figure 3A); for KRAS wild‐type CRC patients, the pooled HR of ACM was 0.81 (95% CI 0.64‐1.03).